Institutional investors purchased a net $1.4 million shares of GHDX during the quarter ended June 2015, and now own 94.19% of the total float, a percentage that is typical for companies in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
DEERFIELD MANAGEMENT CO. LP Bought 1.2 Million shares of Genomic Health Inc
SSGA FUNDS MANAGEMENT, INC. Bought 407.6 Thousand shares of Genomic Health Inc
RENAISSANCE TECHNOLOGIES LLC Bought 230.3 Thousand shares of Genomic Health Inc